BRANDY YARBROUGH: Open Payments
NPI 1275766545 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 80 payments from 18 companies in 2025. Trend: 2023 $1,508 · 2024 $1,567 · 2025 $1,513
Food & beverage: $1,403Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $364 |
| Ardelyx, Inc. | 13 | $264 |
| Janssen Biotech, Inc. | 5 | $171 |
| GENZYME CORPORATION | 4 | $104 |
| Medtronic, Inc. | 1 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $89 |
| Ipsen Biopharmaceuticals, Inc | 2 | $60 |
| Lilly USA, LLC | 2 | $60 |
| Enterra Medical, Inc. | 1 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
Products named: IBSRELA, TREMFYA, RINVOQ, DUPIXENT, INTERSTIM, XIFAXAN, LINZESS, CREON.
Industry payments across GA — which companies pay providers there.
